戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              Dixon analysis shows that epostane inhibits the 3beta-HS
2                                              Dixon analysis with GMP yielded a signature plot for com
3                                              Dixon et al. accurately describe subtle mechanisms of di
4                                              Dixon et al. have highlighted the importance of a politi
5                                              Dixon et al. overlook the fact that contact predicts not
6                                              Dixon et al. suggest that the psychological literature o
7                                              Dixon fat and water MR images were registered to CT imag
8                                              Dixon fat-water separation MR images were manually segme
9                                              Dixon images detected 15 of 47 lung lesions whereas VIBE
10                                              Dixon plots show that inhibition is competitive for the
11                                              Dixon was among the founders of modern immunology and a
12                                              Dixon water-fat distribution was not significantly diffe
13                                              Dixon's up-and-down sequential method was used to determ
14 18)F-FDG PET data were acquired along with 2 Dixon MR-AC maps for each examination.
15 hat maps between the four 2-dimensional (2D) Dixon MR images (water, fat, in-phase, and out-of-phase)
16                                   Although a Dixon plot of the inhibition of IKK-2 by BMS-345541 show
17  a regular 4-compartment segmentation from a Dixon sequence ("Dixon").
18 thyl cations has been quantified by use of a Dixon plot, yielding K = 1.1(3) x 10(-4) M, 4.7(5) x 10(
19 performed by segmentation methods based on a Dixon MR sequence providing up to 4 different tissue cla
20 nt overnight polysomnography and MRI using a Dixon sequence.
21          PET data were reconstructed using a Dixon-based mu map (mu mapDX) and a dual-echo ultrashort
22 ing-based method from CAIPIRINHA-accelerated Dixon images were more accurate than those generated wit
23 ing-based method from CAIPIRINHA-accelerated Dixon images were more accurate than those generated wit
24 ment air pockets from CAIPIRINHA-accelerated Dixon images, with accuracy comparable to that of semiau
25 dard Dixon 4-compartment segmentation alone, Dixon with a superimposed model-based bone compartment,
26 perimposed model-based bone compartment, and Dixon with a superimposed bone compartment and linear AC
27 formed using low-dose CT data for PET/CT and Dixon MRI sequences for PET/MR.
28                       T(1rho) MR imaging and Dixon water-fat MR imaging of the affected upper arms we
29 cated linear, noncompetitive inhibition, and Dixon plot analysis from competition studies with a zinc
30 ual inspection of the thoracic MR-AC map and Dixon images from which it is derived remains crucial fo
31 parison of MAPE between the PASSR method and Dixon segmentation, CT segmentation, and population aver
32 ective 3D turbo spin echo for (31)P-MRI, and Dixon multi-echo GRE for fat-water imaging on a 3 T clin
33 -weighted, short-tau inversion-recovery, and Dixon-type sequences.
34 ilters, statistics for weighted samples, and Dixon's test for outliers, to evaluate protein abundance
35                               The t-test and Dixon's Q-test were applied in order to examine statisti
36 r the VIBE sequence (P < 0.0001 for VIBE and Dixon sequence).
37  learning model: we call this method ZTE and Dixon deep pseudo-CT (ZeDD CT).
38 ral network was trained to transform ZTE and Dixon MR images into pseudo-CT images.
39 ntator on 1200 manually annotated UK Biobank Dixon MRI sequences (50 participants), 221 in-house abdo
40                  Separate indexes defined by Dixon (7 food groups, saturated fat, and alcohol), Melle
41 by Brij-35 was a mixed type as determined by Dixon's plot; however, the inhibition mechanism of endom
42 ment the psychological approach put forth by Dixon et al., but with minimal ancillary assumptions.
43 o solve the resulting problems identified by Dixon et al., we suggest analyzing the psychological pro
44  by Hanes analysis and 0.6 and 0.4 microM by Dixon analysis.
45                      The analysis offered by Dixon et al. fails to acknowledge that the attitudes tha
46                         The early studies by Dixon and his group examining the models of acute or chr
47 us sorbinil-supplemented medium suggested by Dixon plot that neither galactitol nor galactose interac
48 hod for whole-body PET/MR imaging, combining Dixon-based soft-tissue segmentation and model-based bon
49  significantly lower image quality comparing Dixon and VIBE sequence with CT whereas PET from PET/CT
50                                   Conclusion Dixon T2-weighted fat-only and water-only imaging provid
51 ontrast, ellagic acid produced a curvilinear Dixon plot suggesting partial inhibition of nucleotide a
52                                  We describe Dixon-VIBE Deep Learning (DIVIDE), a deep-learning netwo
53 se a fat and water map derived from a 2-echo Dixon MRI sequence in which bone is neglected.
54 the use of a novel free-breathing multi-echo Dixon technique for quantitative myocardial perfusion.
55 ce (MR) imaging protocol (sagittal spin-echo Dixon T2-weighted fat-only and water-only imaging) would
56 sagittal spin-echo T1-weighted and spin-echo Dixon T2-weighted water-only imaging).
57  were assessed with a chemical shift-encoded Dixon sequence and multiecho spin-echo sequence.
58 metric interpolated breath-hold examination (Dixon-VIBE) images currently acquired for AC in some com
59 metric interpolated breath-hold examination) Dixon for attenuation correction and contrast-enhanced V
60 relation was observed between FF(MRF) and FF(Dixon) (R(2) = 0.97, P < .001).
61 red with the three-point Dixon technique (FF(Dixon)), water T2 mapping, and MRF T1-FF, from which the
62 lowest quintiles for all indexes as follows: Dixon (HR: 0.77; 95% CI: 0.69, 0.87), Mellen (HR: 0.78;
63 e lesions, the biases were 5.1% +/- 5.1% for Dixon and 5.2% +/- 5.2% for Model.
64 y a factor of 4 for bone lesions (10.24% for Dixon PET and 2.68% for ZeDD PET) and by a factor of 1.5
65 or of 1.5 for soft-tissue lesions (6.24% for Dixon PET and 4.07% for ZeDD PET).
66 rest was 2.4% +/- 2.5% and 2.7% +/- 2.7% for Dixon and Model, respectively, compared with CT-based AC
67 on was -7.4% +/- 5.3% and -2.9% +/- 5.8% for Dixon and Model, respectively.
68 g for bone detection and gradient echoes for Dixon water-fat separation in a radial 3-dimensional acq
69 n Enders at Harvard, who pointed me to Frank Dixon at Scripps in La Jolla, California, for postdoctor
70                                  Under Frank Dixon, my work examined how antibodies to the glomerular
71 VD than the textural features extracted from Dixon sequences and FDG PET.
72 mated measurements of fat fraction (FF) from Dixon images.
73 segmented separately, 14 muscles total) from Dixon MRI scans (n = 17, 17 scans < 2 weeks post motor v
74 s of affinity that correlated with the ideal Dixon-Webb competitive profile.
75            Three points that are implicit in Dixon et al.'s paradigm-challenging paper serve to make
76 scussing my work in Israel (now mentioned in Dixon et al.'s note 6) on the processes and practices th
77 competitive inhibitor of MgATP with a linear Dixon plot.
78                  This multiecho TSE modified Dixon (mDixon) sequence was optimized by using simulatio
79 is study to implement an algorithm modifying Dixon-based MR imaging datasets for attenuation correcti
80 sing 3-dimensional CAIPIRINHA-accelerated MR Dixon datasets from 35 subjects and was evaluated agains
81 udo-CT images from CAIPIRINHA-accelerated MR Dixon images.
82 he attenuation map was obtained using the MR Dixon method currently available on the Siemens Biograph
83 rove (18)F FDG PET image quality by using MR Dixon fat-constrained images to constrain PET image reco
84 by using a commercially available multipoint Dixon pulse sequence with a 1.5-T MRI system.
85              A single-breath-hold multipoint Dixon-based acquisition was performed with commercially
86  pleural effusions through use of multipoint Dixon fat quantification.
87               In ex vivo studies, multipoint Dixon-derived fat fraction was higher in chylous versus
88  with hepatic MR imaging by using multipoint Dixon techniques is highly reproducible across readers,
89 urpose To assess whether MRI with multipoint Dixon fat quantification allows for noninvasive differen
90 unther (HR: 0.84; 95% CI: 0.73.0.97) but not Dixon (HR: 1.01; 95% CI: 0.80, 1.28).
91 n-based mu maps using the MAVRIC in areas of Dixon signal voids.
92                            A key argument of Dixon et al. in the target article is that prejudice red
93 duced the whole-brain SUV estimation bias of Dixon-based PET/MR AC by 95% compared with reference CT
94 t-specific multiparametric MRI consisting of Dixon MRI and proton-density-weighted ZTE MRI to directl
95  in immunopathology and also cover facets of Dixon's overall contributions to immunology.
96             Purpose To test the potential of Dixon T2-weighted fat-only sequences to replace T1-weigh
97 nd even allowing retrospective processing of Dixon-VIBE data.
98                   This commentary focuses on Dixon et al.'s discussion on the dangers of employing pr
99 ce standard (short-tau inversion recovery or Dixon) techniques.
100 erage of differences between PET(CT) and PET(Dixon) (mean PET(CT)-PET(Dixon) SUV, 0.0006; PET(CT)-PET
101  PET(CT)-PET(Dixon) SUV, 0.0006; PET(CT)-PET(Dixon) SD, 0.0264; 95% confidence interval, [-0.0510,0.0
102 een PET(CT) and PET(Dixon) (mean PET(CT)-PET(Dixon) SUV, 0.0006; PET(CT)-PET(Dixon) SD, 0.0264; 95% c
103  obtained after AC using the Dixon-VIBE (PET(Dixon)), DIVIDE (PET(DIVIDE)), and CT-based (PET(CT)) me
104 tely followed by PET/MR imaging with 2-point Dixon attenuation correction.
105                 The MRI consisted of 2-point Dixon imaging for attenuation correction, standard seque
106 te Free Precession and T(1)-weighted 2-point Dixon sequences covering the entire fetus.
107            PET/MR imaging included a 2-point Dixon water-fat separation method.
108 ue decomposition is achieved using a 3-point Dixon-like decomposition.
109     Proton MR spectroscopy (MRS) and 8-point Dixon MR imaging (MRI) measured muscle fat fraction (FF)
110 ast spin-echo, or water-specific three-point Dixon gradient-echo) was alternated with freehand manipu
111                   Water-specific three-point Dixon images are successful in regions of B0 heterogenei
112                                  Three-point Dixon images were superior to extended two-point Dixon a
113                                  Three-point Dixon imaging provides a robust method for creating fat-
114 on comprised FF mapping with the three-point Dixon method, water T2 mapping, and water T1 mapping bef
115                                A three-point Dixon reconstruction algorithm was used to generate wate
116 aration was performed by using a three-point Dixon reconstruction from in- and opposed-phase black-bl
117 ping of the FF measured with the three-point Dixon technique (FF(Dixon)), water T2 mapping, and MRF T
118 n images were superior to extended two-point Dixon and fat-suppressed images and to images generated
119 t-fraction (SFF) analysis based on a 2-point-Dixon water-fat separation method in whole-body simultan
120                              The three-point-Dixon fat water separation technique was used to determi
121                                 The proposed Dixon motion correction technique was compared to the st
122 R short inversion time inversion-recovery ), Dixon-type liver accelerated volume acquisition ( LAVA l
123 construction is improved over segmentation- (Dixon and Siemens UTE) and registration-based methods, e
124 ing low-dose CT for the PET/CT and segmented Dixon MR imaging data for the PET/MR.
125 d a constraint based on fat/water-separating Dixon MR images that shift activity away from regions of
126 y 3-dimensional dual gradient-echo sequence (Dixon) used for MR imaging-based PET attenuation correct
127 artment segmentation from a Dixon sequence ("Dixon").
128 f-phase echoes, required for chemical shift (Dixon) reconstruction, in the same repetition by using p
129 g the original CT, our synthetic CT, Siemens Dixon-based mu maps, Siemens UTE-based mu maps, and defo
130  29.767, 29.34, and 27.43 dB for the Siemens Dixon-, UTE-, and registration-based mu maps.
131 R AC methods were compared with CT: standard Dixon 4-compartment segmentation alone, Dixon with a sup
132 hesize a pelvis pseudo-CT scan from standard Dixon-VIBE images, allowing for accurate AC in combined
133  a novel AC method that supplements standard Dixon-based tissue segmentation with a superimposed mode
134 is pseudo-CT maps based only on the standard Dixon volumetric interpolated breath-hold examination (D
135 s to assess the reproducibility of standard, Dixon-based attenuation correction (MR-AC) in PET/MR ima
136                                 I argue that Dixon et al. fail to maintain a careful distinction betw
137                           Here, I argue that Dixon et al. have overstated the prevalence of "benevole
138                                          The Dixon fat images, unaffected by the dynamic contrast-enh
139                                          The Dixon magnetic resonance imaging technique was used to q
140                                          The Dixon MRI sequences acquired for attenuation correction
141                                          The Dixon-based method performed substantially worse (the me
142                                          The Dixon-based method performed substantially worse, with a
143 d to separate cortical bone and air, and the Dixon technique has enabled differentiation between soft
144  the gold standard CT-based approach and the Dixon-based method available on the Biograph mMR scanner
145 sing the reference CT-based approach and the Dixon-based method.
146  An algorithm was implemented correcting the Dixon-based mu maps using the MAVRIC in areas of Dixon s
147 er, with a detection rate of 9 of 33 for the Dixon sequence and 15 of 33 for the VIBE sequence (P < 0
148 ned to synthesize pseudo-CT mu-maps from the Dixon images.
149 ined to synthesize pseudo-CT u-maps from the Dixon images.
150 ed 4D MRI volume and the AM derived from the Dixon MR image to generate respiration-synchronized MR i
151    MRI of the lower extremities included the Dixon sequence, multicomponent T2 mapping, and DTI calcu
152 imes smaller than the relative change of the Dixon method.
153 llocation of PET/MR findings by means of the Dixon MRI sequence was comparable to allocation of PET/C
154                       PASSR outperformed the Dixon, CT segmentation, and mean atlas methods by reduci
155 ter, which were significantly lower than the Dixon, CT segmentation, and mean atlas values (P < .01).
156 8%, which was significantly smaller than the Dixon- (100%) and CT- (39%) derived values.
157 re assessed via water-fat contrast using the Dixon method and via water-saturation efficiency using f
158  second non-linear correction step using the Dixon water images to remove residual motion.
159 e SUVs (in g/mL) obtained after AC using the Dixon-VIBE (PET(Dixon)), DIVIDE (PET(DIVIDE)), and CT-ba
160 use of the lack of bone information with the Dixon-based MR sequence, bone is currently considered as
161                                        Three Dixon-based MR AC methods were compared with CT: standar
162                                    Thanks to Dixon's up-and-down method we proved that with the induc
163 dy involving seventy subjects that underwent Dixon MRI of the pelvis.
164 al Consortium grant; Northwestern University Dixon Translational Science Award; Simpson Querrey Lung
165 was examined for both Ag(+) and Cu(2+) using Dixon and Cornish-Bowden plots, where a strong correlati
166 enohumeral models by transfer learning using Dixon-based sequences.
167 57 +/- 0.54, P = 0.0001) or T1-weighted VIBE Dixon MRI (2.57 +/- 0.54, P = 0.0002).
168 h PET [from PET/CT; set A], T1-weighted VIBE Dixon with PET [set B], and T1-weighted TSE with PET [bo
169  interpolated breath-hold examination (VIBE) Dixon sequence for attenuation correction and an unenhan
170             Training by and association with Dixon and his other postdoctoral fellows, my independent
171 with deep MRAC (-0.7% +/- 1.1) compared with Dixon-based soft-tissue and air segmentation (-5.8% +/-
172                             We disagree with Dixon et al. by maintaining that prejudice is primarily
173 r fat-suppression inhomogeneity indexes with Dixon (1.0%) and SHARP (2.4%) compared with CHESS (10.7%
174                                 In line with Dixon et al.'s argument, I contend that prejudice should
175 25.5% +/- 7.9% underestimation observed with Dixon was reduced to -4.9% +/- 6.7% with Model.
176 nd muscular fat fraction was quantified with Dixon-type imaging.
177  T1-weighted 3-dimensional MRI sequence with Dixon-based fat and water separation was also acquired a

 
Page Top